Anticoagulants clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Anticoagulation Profile in Pregnant Women Treated with Three Times a Day of Low Molecular Weight Heparin (LMWH)
open to eligible females ages 18 years and up
Pregnancy is associated with a increased risk of developing blood clots. There is nearly a 5 times greater risk of developing a blood clot in pregnancy. Lovenox is a medication that helps to prevent the body from developing clots. It is safe to use…
at UC Irvine
Our lead scientists for Anticoagulants research studies include Afshan Hameed.
Last updated: